AamodtR.L., CoonJ.S., DeitchA., deVere WhiteR.W., KossL.G., MelamedM.R., WeinsteinR.S., WheelessL.L.: Flow cytometric evaluation of bladder cancer: recommendations of the NCl flow cytometry network for bladder cancer. World J. Urol., 10: 63–67, 1992.
2.
AbelP.D., HallR.R., WilliamsG.: Should pT1 transitional cell cancers of the bladder stili be classified as superficial?Br. J. Urol., 62: 235–239, 1988.
3.
AmbersonJ.B., LainoJ.P.: Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma. J. Urol., 149: 42–45, 1993.
4.
BadalamentR.A., GayH., WhitmoreW.R., HerrH.W., FairW.R., OettgenH.K., MelamedM.R.: Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry. Cancer, 58: 2751–2760, 1986.
5.
BerezneyR., CoffeyD.S.: Identification of a nuclear protein matrix. Biochem. Biophys. Res. Comm., 60: 1410–1417, 1974.
6.
BergkvistA., LjungqvistA., MobergerG.: Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand., 130: 371–378, 1965.
7.
BoonM.E., van der PoelH.G., TanL.P. C.J., KokL.P.: Effect of embedding methods versus fixative type on karyometric measures. Anal. Quant. Cytol. Histol., 16: 131–136, 1994.
8.
BowieJ.E., YoungI.T.: An analysis technique for biological shape - II. Acta Cytol., 21: 455–462, 1977.
9.
CantJ.D., MurphyW.M., SolowayM.S.: Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. Cancer, 57: 2119–2122, 1986.
10.
CollsteL.G., DevonecM., DarzynkiewiczZ., TraganosF., SharplessT.K., WhitmoreW.F., MelamedM.R.: Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid. Cancer, 45: 2389–2394, 1980.
11.
ColpaertC., GoovaertsG., BuyssensN.: Factors influencing the subjective grading of bladder cancer. Virchows Arch. A, 411: 479–484, 1987.
12.
EspostiP.L., ZajicekJ.: Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings. Acta Cytol., 16: 529–536, 1972.
13.
GetzenbergR.H.: Nuclear matrix and the regulation of gene expression: tissue specificity. J. Cell Biochem., 55: 22–31, 1994.
14.
HeneyN.M., AhmedS., FlanaganM.J., FrableW., CorderM.P., HafermanM.D., HawkinsI.R.: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083–1086, 1983.
15.
HorbathK., MaierU., SusaniM.: Value of bladder wash cytology in the follow-up of patients with bladder carcinoma receiving intravesical chemoprophylaxis with mitomycin C. Eur. Urol., 20: 93–96, 1991.
16.
KleinF.A., HerrH.W., SoganiP.C., WhitmoreW.F., MelamedM.R.: Detection and follow-up of carcinoma of the urinary bladder by flow cytometry. Cancer, 50: 389–396, 1982.
17.
KoshikawaT., LeyhH., SchenckU.: Diagnostische Probleme der Urinzytologie nach lokaler Instillationstherapie mit Mitomycin beim oberflachlichen Harnblasenkarzinom. Akt. Urol., 22: 209–212, 1991.
18.
KossL.G., WerstoR.P., SimmonsD.A., DeitchD., HerzF., FreedS.Z.: Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors. Cancer, 64: 916–924, 1989.
19.
KossL.G., BartelsP.H., WiedG.L.: Computer-based diagnostic analysis of cells in the urinary sediment. J. Urol., 123: 846–852, 1980.
20.
KossL.G., DeitchD., RamanathanR., ShermanA.B.: Diagnostic value of cytology of voided urine. Acta Cytol., 29: 810–816, 1985.
21.
MostofiF.K., SobinL.H., ToroniH.: Histological typing of urinary bladder tumours. International histological classification of tumours. N. 10. WHO, Geneva, 1973.
22.
MurphyW.M., EmersonL.D., ChandlerR.W., MoinuddinS.M., SolowayM.S.: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J. Urol., 136: 815–819, 1986.
23.
PientaK.J., WardW.S.: An unstable nuclear matrix may contribute to genetic instability. Med. Hypotheses, 42: 45–52, 1994.
24.
PientaK.J., PartinA.W., CoffeyD.S.: Cancer as a disease of DNA organisation and dynamic cell structure. Cancer Res., 49: 2525–2532, 1989.
25.
RaabS.S., LenelJ.C., CohenM.B.: Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer, 74: 1621–1626, 1994.
26.
RubbenH., Graf-DobbersteinC., OstwaldR., StauffenbergA., JaegerN., DeutzF.J., SteffensL., GianiG.: Prospective randomized study of adjuvant therapy after complete resection of superficial bladder cancer: mitomycin C versus BCG Connaught versus TUR alone. In: deKernionJ.B. (ed): Immunotherapy of urological tumors.Edinburgh: Churchill Livingstone, Chapter 3, pp. 27–36.
27.
ShermanA.B., KossL.G., AdamsS.E.: Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal. Quant. Cytol. Histol., 6: 112–118, 1984.
28.
ShermanA.B., KossL.G., WyschogrodD., MelderK.H., EppichE.M., BalesCE.: Bladder cancer diagnosis by computer image analysis of cells in the sediment of voided urine using a video scanning system. Anal. Quant. Cytol. Histol., 8: 177–182, 1986.
29.
SolowayM.S.: Intravesical therapy for bladder cancer. Urol. Clin. N. Am., 15: 661–672, 1988.
30.
van der PoelH.G., BoonM.E., KokL.P., TolboomJ., van der MeulenB., OomsE.C.M.: Can cytomorphometry replace histomorphometry in grading of bladder tumours. Virchows Arch. [Pathol. Anat.], 413: 249–255, 1988.
31.
van der PoelH.G., van CauberghR.D., BoonM.E., DebruyneF.M.J., SchalkenJ.A.: Karyometry in recurrent superficial transitional cell tumors of the bladder. Urol. Res., 20: 375–381, 1992.
32.
van der PoelH.G., OosterhofG.O.N., SchaafsmaH.E., TilburgWiersma-V. A., DebruyneF.M.J., SchalkenJ.A.: Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder. EORTC Genitourinary Group Monograph11: Recent Progress in Bladder and Kidney Cancer. ed. FH Schròder, pp. 9–18, 1992.
33.
van der PoelH.G., SchaafsmaH.E., VooijsG.P., DebruyneF.M.J., SchalkenJ.A.: Quantitative light microscopy in urologic oncology. J. Urol., 148: 1–13, 1992.
34.
van der PoelH.G., BoonM.E.: Microwave-antigen retrieval for proliferation analysis (MIB-1) and quanticyt karyometry of bladder washings. Eur. J. Morphol.32: 71–78, 1994.
35.
ZeinT., WaismanZ., EnglanderL.S., GamarraM., LopezC., HubenR.P., PontesJ.E.: Evaluation of bladder washings and urine cytology for the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J. Urol., 132: 670–671, 1984.